Market Tracker

04/25 6:27am ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

4.10
Delayed Data
As of Apr 24
 -0.03 / -0.73%
Today’s Change
3.08
Today|||52-Week Range
10.68
+31.41%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close4.13
Today’s open4.14
Day’s range4.01 - 4.19
Volume26,779
Average volume (3 months)54,901
Market cap$82.1M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+84.46%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales7.00
Price/Book0.60

Competitors

 Today’s
change
Today’s
% change
CTSOCytosorbents Corp-0.10-1.32%
CDTXCidara Therapeutics ...+0.10+2.53%
CDXCChromadex Corp-0.25-5.90%
NATRNatures Sunshine Pro...+0.10+1.07%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$13.6M
Annual profit (last year)-$52.9M
Net profit margin-389.49%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer &
Executive VP
Jeffrey Hackman
Chief Financial Officer &
Senior Vice President
Michael Dennis Price
Corporate headquarters
Vancouver, British Columbia

Forecasts